NCT05293444

Brief Summary

It's a randomized control trial to compare the effect of preoperative carbohydrate loading versus fasting on post operative insulin resistance after donor hepatectomy in terms of donor outcomes. Investigator will analyze the data and elucidate the value of post operative insulin resistance in reducing the occurrence of complications, length of hospital stay and fastening the recovery in donors of Live donor liver transplantation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

February 25, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

December 5, 2023

Status Verified

October 1, 2023

Enrollment Period

10 months

First QC Date

February 25, 2022

Last Update Submit

December 3, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • To compare the insulin resistance by HOMA-IR(Homeostatic model assessment for insulin resistance) on postoperative day 2 between preoperative carbohydrate loading and conventional fasting group after donor hepatectomy.

    Post operative day 2

Secondary Outcomes (16)

  • To compare the functional recovery by total bilirubin on postoperative day 1

    Post operative day 1

  • To compare the functional recovery by PT/INR on postoperative day 1

    Post operative day 1

  • To compare the functional recovery by total bilirubin on postoperative day 3.

    Post operative day 3

  • To compare the functional recovery by PT/INR on postoperative day 3.

    Post operative day 3

  • To compare the functional recovery by total bilirubin on postoperative day 5.

    Post operative day 5

  • +11 more secondary outcomes

Study Arms (2)

Overnight fasting

OTHER

overnight fasting(minimum 6 hrs) for control group.

Other: overnight fasting

Maltodextrin

EXPERIMENTAL

Route: Oral Dose: * 400 ml at 10PM night before surgery(12.5g/100ml) * 200 ml in the morning at 6 AM (12.5g/100ml) on the day of surgery.

Dietary Supplement: Maltodextrine

Interventions

MaltodextrineDIETARY_SUPPLEMENT

400 ml at 10PM night before surgery(12.5g/100ml) 200 ml in the morning at 6 AM (12.5g/100ml) on the day of surgery.

Maltodextrin

no intervention

Overnight fasting

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All consecutive live liver donors who undergo donor hepatectomy at ILBS

You may not qualify if:

  • Donor hepatectomy for ALF(acute liver failure) recipient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Liver and Biliary Sciences

New Delhi, 110070, India

Location

Related Publications (1)

  • Kumar M, Patil NS, Mohapatra N, Yadav A, Sindwani G, Dhingra U, Thomas S, Pamecha V. Preoperative carbohydrate loading reduces perioperative insulin resistance and hastens functional recovery of remnant liver after living donor hepatectomy: An open-label randomized controlled trial. Hepatol Int. 2025 Oct;19(5):1151-1161. doi: 10.1007/s12072-025-10831-5. Epub 2025 May 19.

Study Officials

  • Viniyendra Pamecha, MS, FRCS(UK)

    Institute of Liver and Biliary Sciences, New Delhi

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2022

First Posted

March 24, 2022

Study Start

February 1, 2022

Primary Completion

November 30, 2022

Study Completion

November 30, 2022

Last Updated

December 5, 2023

Record last verified: 2023-10

Locations